Page 408 - WSAVA2017
P. 408

An Urban Experience
33. Schreeg ME, Marr HS, Tarigo J, et al. Pharmacogenomics of Cytauxzoon felis cytochrome b: implications for atovaquone and azithromycin therapy in domestic cats with cytauxzoonosis. J Clin Microbiol. 2013;51:3066-3069.
34. Lewis KM, Cohn LA, Marr HS, Birkenheuer AJ. Failure of efficacy and adverse events associated with dose-intense diminazene diaceturate treatment of chronic Cytauxzoon felis infection in five cats. J Feline Med Surg. 2014;16:157-163.
35. Reichard MV, Thomas JE, Arther RG, et al. Efficacy of an imidacloprid 10% / flumethrin 4.5% collar (Seresto®, Bayer) for preventing the transmission of Cytauxzoon felis to domestic cats by Amblyomma americanum. Parasitol Res. 2013;112 Suppl 1:11-20.
36. Breitschwert EB, Abrams-Ogg AC, Lappin MR, et al. Molecular evidence supporting Ehrlichia canis-like infection in cats. J Vet Intern Med. 2002;16:642- 649.
37. Aguirre E, Tesouro MA, Amusategui I, et al. Assessment of feline ehrlichiosis in central Spain using serology and a polymerase chain reaction technique. Ann N Y Acad Sci. 2004;1026:103-135.
38. Ayllón T, Diniz PP, Breitschwerdt EB, et al. Vector-borne diseases in client-owned and stray cats from Madrid, Spain. Vector Borne Zoonotic Dis. 2012;12:143-150.
39. Solano-Gallego L, Hegarty B, Espada Y, Llull J, Breitschwerdt E. Serological and molecular evidence of exposure to arthropod-borne organisms in cats from northeastern Spain. Vet Microbiol. 2006;118:274-277.
40. Tabar MD, Altet L, Francino O, et al. Vector-borne infections in cats: molecular study in Barcelona area (Spain). Vet Parasitol. 2008;151:332-336.
41. Braga ÍA, dos Santos LG, de Souza Ramos DG, et al. Detection of Ehrlichia canis in domestic cats in the central-western region of Brazil. Braz J Microbiol. 2014;45:641-645.
42. Bouloy RP, Lappin MR, Holland CH, et al. Feline ehrlichiosis: clinical case and serologic survey. J Am Vet Med Assoc. 1994;204:1475-1478.
43. Peavy GM, Holland CJ, Dutta SK, et al. Suspected Ehrlichia infection in a household of cats. J Am Vet Med Assoc. 1997;210:231-234.
44. Beaufils JP, Marin-Granel, Jumelle P, et al. Ehrlichiosis in cats. A retrospective study of 21 cases. Pratique Medicale Chirurgicale de l’Animal de Compagnie. 1999;34:587-596
45. Braga IA, dos Santos LG, Melo AL, et al. Hematological values associated to the serological and molecular diagnostic in cats suspected of Ehrlichia canis infection. Rev Bras Parasitol Vet. 2013;22:470-474.
46. Neer TM, Breitschwerdt EB, Greene RT, Lappin MR. Consensus statement on ehrlichial disease of small animals from the Infectious Disease Study Group of the ACVIM. J Vet Intern Med. 2002;16:309-315
47. Bayliss DB, Morris AK, Horta MC, et al. Prevalence of Rickettsia species antibodies and Rickettsia species DNA in the blood of cats with and without fever. J Feline Med Surg. 2009;11;266-270.
48. Segura F, Pons I, Miret J, et al. The role of cats in the eco-epidemiology of spotted fever group diseases. Parasit Vectors. 2014;7:353.

   406   407   408   409   410